Evidence for the possible involvement of the P2Y6 receptor in Ca2+ mobilization and insulin secretion in mouse pancreatic islets

Purinergic Signalling

Volumn 4, Issue 4, 2008, Pages 365-375

  Ohtani, Masahiro ^a   Suzuki, Jun Ichiro ^a   Jacobson, Kenneth A ^b   Oka, Takami ^a  

^a MUSASHINO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Calcium; Insulin; P2Y1nucleotide receptor; Pancreatic islets; Purines; Pyrimidines

Indexed keywords

EID: 56549124788     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-008-9122-2     Document Type: Article

References (41)

1. Ämmälä C, Eliasson L, Bokvist K, Berggren PO, Honkanen RE, Sjöholm Ä et al (1994) Activation of protein kinases and inhibition of protein phosphatases play a central role in the regulation of exocytosis in mouse pancreatic beta cells. Proc Natl Acad Sci USA 91:4343-4347. doi: 10.1073/pnas.91.10.4343
2. 2+ pool. Biochem J 265:203-211
3. Bertrand G, Chapal J, Puech R, Loubatières-Mariani MM (1991) Adenosine-5′-O-(2-thiodiphosphate) is a potent agonist at P2 purinoceptors mediating insulin secretion from perfused rat pancreas. Br J Pharmacol 102:627-630
4. Blachier F, Malaisse WJ (1988) Effect of exogenous ATP upon inositol phosphate production, cationic fluxes and insulin release in pancreatic islet cells. Biochim Biophys Acta 970:222-229. doi: 10.1016/ 0167-4889(88)90182-6
5. Burnstock G (1993) Physiological and pathological roles of purines: An update. Drug Dev Res 28:195-206. doi: 10.1002/ddr.430280303
6. Chapal J, Hillarie-Buys D, Bertrand G, Pujalte D, Petit P, Loubatières-Miriani MM (1997) Comparative effects of adenosine-5′-triphosphate and related analogues on insulin secretion from the rat pancreas. Fundam Clin Pharmacol 11:537-545
7. Chevassus H, Roig A, Belloc C, Lajoix AD, Broca C, Manteghetti M et al (2002) P2Y receptor activation enhances insulin release from pancreatic β-cells by triggering the cyclic AMP/protein kinase A pathway. Naunyn Schmiedebergs Arch Pharmacol 366:464-469. doi: 10.1007/ s00210-002-0620-4
8. Coutinho-Silva R, Parson M, Robson T, Burnstock G (2001) Change in expression of P2 receptors in rat and mouse pancreas during development and aging. Cell Tissue Res 306:373-383. doi: 10.1007/s004410100458
9. Coutinho-Silva R, Parson M, Robson T, Lincoln J, Burnstock G (2003) P2X and P2Y purinoceptor expression in pancreas from streptozotocin-diabetic rats. Mol Cell Endocrinol 204:141-154. doi: 10.1016/S0303-7207(03)00003-0
10. Doyle ME, Egan JM (2003) Pharmacological agents that directly modulate insulin secretion. Pharmacol Rev 55:105-131. doi: 10.1124/pr.55.1.7
11. Farret A, Vignaud M, Dietz S, Vignon J, Petit P, Gross R (2004) P2Y purinergic potentiation of glucose-induced insulin secretion and pancreatic β-cell metabolism. Diabetes 53:S63-S66. doi: 10.2337/ diabetes.53.suppl_3.S63
12. Fernandez-Alvarez J, Hillarie-Buys D, Loubatières-Miriani MM, Gomis R, Petit P (2001) P2 receptor agonists stimulate insulin release from human pancreatic islets. Pancreas 22:69-71. doi: 10.1097/ 00006676-200101000-00012
13. 2+ influx by extracellular ATP in a pancreatic β-cell line (HIT). Biochim Biophys Acta 1012:107-115. doi: 10.1016/0167-4889(89)90018-9
14. Gilon P, Henquin JC (2001) Mechanisms and physiological significance of the cholinergic control of pancreatic β-cell function. Endocr Rev 22:565-604. doi: 10.1210/er.22.5.565
15. Hauge-Evans AC, Squires PE, Belin VD, Roderigo-Milne H, Ramracheya RD, Persaud SJ et al (2002) Role of adenine nucleotides in insulin secretion from MIN6 pseudoislets. Mol Cell Endocrinol 191:167-176. doi: 10.1016/ S0303-7207(02)00051-5
16. Hellman B, Dansk H, Grapengiesser E (2004) Pancreatic β-cells communicate via intermittent release of ATP. Am J Physiol Endocrinol Metab 286:E759-E765. doi: 10.1152/ajpendo.00452.2003
17. 2+ oscillations in pancreatic β-cells. Biochim Biophys Acta 1113:295-305
18. Hutton JC, Penn EJ, Pashavaria M (1983) Low-molecular-weight constituents of isolated insulin secretory granules. Bivalent cations, adenine nucleotides and inorganic phosphate. Biochem J 210:297-305
19. Jacobson KA, Costanzi S, Ohno M, Joshi BV, Besada P, Xu B et al (2004) Molecular recognition at purine and pyrimidine nucleotide (P2) receptors. Curr Top Med Chem 4:805-819. doi: 10.2174/1568026043450961
20. Jacobson KA, Jarvis MF, Williams M (2002) Purine and pyrimidine (P2) receptors as drug targets. J Med Chem 45:4057-4093. doi: 10.1021/ jm020046y
21. 2+ in islet cell clusters show that glucose rapidly recruits β-cells and gradually increases the individual cell response. Diabetes 50:540-550. doi: 10.2337/diabetes.50.3.540
22. Knaack D, Fiore DM, Surana M, Leiser M, Laurance M, Fusco-DeMane D et al (1994) Clonal insulinoma cell line that stably maintains correct glucose responsiveness. Diabetes 43:1413-1417. doi: 10.2337/diabetes.43.12.1413
23. Lazarowski ER, Boucher RC, Harden TK (2003) Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. Mol Pharmacol 64:785-795. doi: 10.1124/mol.64.4.785
24. 1 receptor is involved in the maintenance of glucose homeostasis and in insulin secretion in mice. Purinergic Signal 1:145-151. doi: 10.1007/s11302-005-6209-x
25. 2+ influx and membrane depolarization. J Biol Chem 266:3449-3457
26. Loubatières-Mariani MM, Chapal J, Lignon F, Valette G (1979) Structural specificity of nucleotides for insulin secretory action from the isolated perfused rat pancreas. Eur J Pharmacol 59:277-286. doi: 10.1016/0014-2999(79)90291-7
27. Lugo-Garcia L, Filhol R, Lajoix AD, Gross R, Petit P, Vignon J (2007) Expression of purinergic P2Y receptor subtypes by INS-1 insulinoma beta-cells: A molecular and binding characterization. Eur J Pharmacol 568:54-60. doi: 10.1016/j.ejphar.2007.04.012
28. Ohtani M, Oka T, Badyuk M, Xiao Y, Kellar KJ, Daly JW (2006) Mouse β-TC6 insulinoma cells: High expression of functional αβ4 nicotinic receptors mediating membrane potential, intracellular calcium, and insulin release. Mol Pharmacol 69:899-907
29. 6 receptors. Biochem Biophys Res Commun 370:499-503. doi: 10.1016/j.bbrc.2008.03.119
30. Petit P, Bertrand G, Schmeer W, Henquin JC (1989) Effects of extracellular adenosine nucleotides on the electrical, ionic and secretory events in mouse pancreatic β-cells. Br J Pharmacol 98:875-882
31. Petit P, Manteghetti M, Puech R, Loubatières-Mariani MM (1987) ATP and phosphate-modified adenine nucleotide analogues. Effects on insulin secretion and calcium uptake. Biochem Pharmacol 36:377-380. doi: 10.1016/0006-2952(87)90297-8
32. Petit P, Hillarie-Buys D, Manteghetti M, Debrus S, Chapal J, Loubatières-Mariani MM (1998) Evidence for two different types of P2 receptors stimulating insulin secretion from pancreatic B cell. Br J Pharmacol 125:1368-1374. doi: 10.1038/sj.bjp.0702214
33. Poulsen CR, Bokvist K, Olsen HL, Høy M, Capito K, Gilon P (1999) Multiple sites of purinergic control of insulin secretion in mouse pancreatic β-cells. Diabetes 48:2171-2181. doi: 10.2337/ diabetes.48.11.2171
34. Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492
35. Ribes G, Bertrand G, Petit P, Loubatieres-Mariani MM (1988) Effects of 2-methylthio ATP on insulin secretion in the dog in vivo. Eur J Pharmacol 155:171-174. doi: 10.1016/0014-2999(88)90418-9
36. Salehi A, Quader SS, Grapengiesser E, Hellman B (2005) Inhibition of purinoceptors amplifies glucose-stimulated insulin release with removal of its pulsatility. Diabetes 54:2126-2131. doi: 10.2337/ diabetes.54.7.2126
37. Verspohl EJ, Johannwille B, Waheed A, Neye H (2002) Effect of purinergic agonists and antagonists on insulin secretion from INS-1 cells (insulinoma cell line) and rat pancreatic islets. Can J Physiol Pharmacol 80:562-568. doi: 10.1139/y02-079
38. Vial C, Evans RJ (2002) P2X1 receptor-deficient mice establish the native P2X receptor and a P2Y6-like receptor in arteries. Mol Pharmacol 62:1438-1445. doi: 10.1124/mol.62.6.1438
39. Von Kügelgen I (2006) Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 110:415-432. doi: 10.1016/ j.pharmthera.2005.08.014
40. Williams M, Jarvis MF (2000) Purinergic and pyrimidinergic receptors as potential drug targets. Biochem Pharmacol 59:1173-1185. doi: 10.1016/ S0006-2952(99)00341-X
41. 2+ response to extracellular adenosine triphosphate in pancreatic β-cells in rats and mice. Endocrine 22:185-192. doi: 10.1385/ENDO:22:3:185